NEW YORK (Reuters Health) – When asymptomatic patients with a supratherapeutic INR are seen in the emergency department, can they be treated as outpatients or should they be…
NEW Y ORK (Reuters Health) – For patients with rheumatoid arthritis, the selective T-cell co-stimulation modulator abatacept works just as well whether administered subcutaneously (SC) once a week…
NEW YORK (Reuters Health) – In a small preliminary study, a combination pill containing 85 milligrams of sumatriptan and 500 milligrams of naproxen sodium formulated in a rapid…
NEW YORK (Reuters Health) – For repairing simple lacerations, tissue adhesives produce similar cosmetic results as sutures, staples or adhesive tapes. They’re also quicker and less painful. That’s…
NEW YORK (Reuters Health) – Patients with moderate-to-severe chronic obstructive pulmonary disease have a greater improvement in dyspnea and health status after 12 weeks of treatment with inhaled…
NEW YORK (Reuters Health) – For assessing subsequent risk of stroke in patients who’ve had a transient ischemic attack, the so-called ABCD2 instrument is not sensitive or specific…
NEW YORK (Reuters Health) – Based on their review of screening instruments for alcohol and drug misuse, a Canadian team recommends using three quick questions in the emergency…
NEW YORK (Reuters Health) – Subcutaneous immunotherapy is at least as effective as drug therapy in controlling symptoms of seasonal allergic rhinitis, even in the first season after…
NEW YORK (Reuters Health) – Patients with hypercholesterolemia who do not reach target lipid levels with rosuvastatin have a better change of reaching their goals by adding ezetimibe…
NEW YORK (Reuters Health) – In adults with overactive bladder and nocturia, treatment with solifenacin, may improve quality of sleep and sleep-related quality of life by decreasing the…